Close Menu

The British government has given its approval for the creation of a £30 million stem cell therapy center, part of a £220 million program to turn British stem cell researchers' discoveries into "a new multimillion-pound industry to help drive Britain's recovery," reports the Guardian's Rupert Neate. The stem cell center, which is slated to open in April 2012, will take advantage of the UK's leadership in stem cell research, Neate says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.